Filling the gaps: future treatment options for mild asthma

P. O'Byrne (Hamilton (ON), Canada)

Source: International Congress 2018 – The complexities of managing mild asthma
Session: The complexities of managing mild asthma
Session type: Hot topics
Number: 5151
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. O'Byrne (Hamilton (ON), Canada). Filling the gaps: future treatment options for mild asthma. International Congress 2018 – The complexities of managing mild asthma

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of moderate persistent asthma: new options
Source: Annual Congress 2007 - Pharmacological treatment of mild to moderate persistent asthma: new approaches
Year: 2007


Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007

Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013


Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Recommended new therapies for severe asthma and the future
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Are current treatment protocols adequate for children with mild intermittent asthma?
Source: Eur Respir J 2005; 26: Suppl. 49, 397s
Year: 2005

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
Source: Eur Respir Rev, 27 (147) 170076; 10.1183/16000617.0076-2017
Year: 2018



The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011


A new GINA resource in 2018: a practical guide for assessing and managing difficult-to-treat and severe asthma
Source: International Congress 2018 – GINA 2018 and beyond: shaping the future of asthma management
Year: 2018


Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015



Is mild asthma outside the guidelines?
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011


Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018
Year: 2018



A pragmatic guide to choosing biologic therapies in severe asthma
Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
Year: 2021